1FAMILY 1HEALTH PHARMACY INC. – Trademark Portfolio
Entity Type: 03
1FAMILY 1HEALTH PHARMACY INC. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include PROBIBIEN, PROBIVIEN, LIVERTRIO+, LIVERTRIOX, and 1FAMILY 1HEALTH. The owner is based in MIAMI, FL.
2803 SW 27TH AVE
MIAMI, FL 33133
Showing of trademarks Trademarks
Trademark Classifications
1FAMILY 1HEALTH PHARMACY INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does 1FAMILY 1HEALTH PHARMACY INC. have?
1FAMILY 1HEALTH PHARMACY INC. has 6 U.S. trademarks filed with the USPTO. Of these, 6 registered.
What trademark classes does 1FAMILY 1HEALTH PHARMACY INC. file in?
1FAMILY 1HEALTH PHARMACY INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are 1FAMILY 1HEALTH PHARMACY INC.'s most well-known trademarks?
1FAMILY 1HEALTH PHARMACY INC.'s registered trademark portfolio includes well-known marks such as PROBIBIEN, PROBIVIEN, LIVERTRIO+, LIVERTRIOX, and 1FAMILY 1HEALTH. These are among 6 currently registered trademarks in the portfolio.
What is 1FAMILY 1HEALTH PHARMACY INC.'s trademark registration success rate?
1FAMILY 1HEALTH PHARMACY INC. has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.